Publicaciones (59) Publicaciones de HERMINIA GONZALEZ NAVARRO

2024

  1. Light deficiency in Apoe−/−mice increases atheroma plaque size and vulnerability by modulating local immunity

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 4

2023

  1. CCL17 and CCL22 chemokines are upregulated in human obesity and play a role in vascular dysfunction

    Frontiers in Endocrinology, Vol. 14

  2. Ruleta de palabras: uso para consolidar el aprendizaje en Bioquímica

    In-Red 2023. IX Congreso Nacional de Innovación Educativa y Docencia en Red: Modelos transformadores docentes para un aprendizaje a lo largo de la vida (Universidad Politécnica de Valencia = Universitat Politècnica de València), pp. 944-950

  3. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor

    Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 1, pp. 1-11

2022

  1. Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone Peptide-Derived G Protein Coupled Receptor Agonists

    Nutrients, Vol. 14, Núm. 18

  2. Vascular smooth muscle cell phenotype is modulated by ligands of the lymphotoxin β receptor and the tumor necrosis factor receptor

    Clinica e Investigacion en Arteriosclerosis

2021

  1. Dissecting abdominal aortic aneurysm is aggravated by genetic inactivation of light (Tnfsf14)

    Biomedicines, Vol. 9, Núm. 11

  2. Overexpression of glucose 6 phosphate dehydrogenase preserves mouse pancreatic beta cells function until late in life

    Free Radical Biology and Medicine, Vol. 164, pp. 149-153

  3. Postprandial triglyceridaemia is modulated by insulin resistance but not by grade of obesity in abdominal and morbid obese subjects

    International Journal of Clinical Practice, Vol. 75, Núm. 4

  4. Therapies for the treatment of cardiovascular disease associated with type 2 diabetes and dyslipidemia

    International Journal of Molecular Sciences, Vol. 22, Núm. 2, pp. 1-27

2020

  1. A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease

    Non-coding RNA, Vol. 6, Núm. 2

  2. Dapagliflozin does not modulate atherosclerosis in mice with insulin resistance

    International Journal of Molecular Sciences, Vol. 21, Núm. 23, pp. 1-18

  3. Impact of cholesterol metabolism in immune cell function and atherosclerosis

    Nutrients, Vol. 12, Núm. 7, pp. 1-19

  4. Srebf2 locus overexpression reduces body weight, total cholesterol and glucose levels in mice fed with two different diets

    Nutrients, Vol. 12, Núm. 10, pp. 1-15

  5. TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity

    Cell Reports, Vol. 33, Núm. 4

2019

  1. Aging in Rodents

    Encyclopedia of Biomedical Gerontology: Volume 1-3 (Elsevier), pp. V1-73-V1-87

  2. Aging in rodents

    Encyclopedia of Biomedical Gerontology (Elsevier), pp. 73-87

  3. Anti-inflammatory Therapies for Cardiovascular Disease: Signaling Pathways and Mechanisms

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 767-773

  4. Changes in CDKN2A/2B expression associate with T-cell phenotype modulation in atherosclerosis and type 2 diabetes mellitus

    Translational Research, Vol. 203, pp. 31-48

  5. Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis

    Diabetologia, Vol. 62, Núm. 11, pp. 2143-2157